Gas Transport Characteristics of Hemocorrectors and Perfusates Based on Perfluorocarbon Blood-Substituting Emulsions-Reference-Cited by-同舟云学术

Gas Transport Characteristics of Hemocorrectors and Perfusates Based on Perfluorocarbon Blood-Substituting Emulsions

Published:2020-06-01 Issue:2 Volume:21 Page:147-155
ISSN:2335-075X
Container-title:Serbian Journal of Experimental and Clinical Research
language:en
Short-container-title:

Author:

Vorobyev Sergey Ivanovich¹,Kutyshenko Viktor Pavlovich²,Bolevich Sergey Brankovich¹,Votrin Sergey Vladimirovich¹³,Orlova Alexandra Sergeyevna¹,Bolevich Stefani¹,Morozova Elena Mihaylovna¹,Kartashova Maria Konstatinovna¹

Affiliation:

1. Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation ( Sechenov University ),

2. Institute of theoretical and experimental biophysics of the Rusian Academy of Sciences ( Pushchino , Russia )

3. Scientific research laboratory for biological and physical-chemical study of perfluoral substances Ltd . ( Moscow , Russia )

Abstract

Abstract This review summarizes the data regarding the gas transport characteristics of hemocorrection and perfusates on the basis of low concentrated drugs nano-sized perfluorocarbonic 20% Perftoran (a blood substitute, it is allowed for clinical use in Russia), 20% Ftoremulsion III (an improved blood substitute, registered in Russia), 10-20% Perfusol (a perfusion solution for perfusion of the isolated heart), 20% Ftorem (a cardioplegic emulsion for surgeries on the stopped heart) used in the biomedical field. The compensation of blood loss using traditional plasma substitutes without the gas transport function or with low gas transport characteristics leads to a decrease in the oxygen capacity of the resulting mixture and subsequently to deterioration in the oxygen transport characteristics of blood. The synthetic gas-transport blood substitutes can be used in the treatment of various forms of ischemia, such as carbon monoxide poisoning. Furthermore, recent results regarding the mechanism of COVID19 infection indicate a possible use of the synthetic gas-transport blood substitutes in the treatment and therapy of COVID19 infected patients.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Link

https://www.sciendo.com/pdf/10.2478/sjecr-2020-0020

Reference23 articles.

1. 1. Afonin NI, Doronina NN. Fluorocarbons as possible blood substitutes for oxygen carriers. Problems of Hematology. 1981; 24(1): 41-45.

2. 2. Beloyartsev FF. Perfluorinated carbon in biology and medicine. Perfluorinated carbon in biology and medicine: SB. Pushchino. 1980; 5-21.

3. 3. Beloyartsev FF, Kaidash AN, Islamov BI. Cardioplegia with fluorocarbon emulsion as a method of protecting the myocardium during heart operations. Medico-biological aspects of perfluorocarbon emulsions application. Pushchino SB. 1983. pp. 116-127.

4. 4. Vorobyev SI, Vasiliev AE, Islamov BI. Evaluation of the possibility of using perfluorocarbon emulsion for normothermic perfusion of an isolated heart. Pathophysiology and experimental therapy. 1991; N6: 34-36.

5. 5. Vorobyev SI, Ladilov YuV, Islamov BI. Anti-ischemic effect of perfluorocarbon emulsion on the myocardium of dogs. Bulletin of experimental biology and medicine. 1991. No. 2. C.10.1007/BF00842667

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficiency of the use of perfluorocarbon gas transport drugs for various forms of anemia in animals;Revista de la Universidad del Zulia;2021-01-29